SUMMARY. We tested the hypothesis that hypertrophy of the human heart is associated with the redistribution of ventricular isomyosins. Human cardiac myosin was isolated from autopsy samples of left ventricular free wall of patients with cardiac hypertrophy and of fetal, young, and adult subjects without heart disease. The following parameters were studied: elecrrophoreric migration in denaturing and non-denaturing conditions; immunological cross-reactivities with three different types of antibodies; and early phosphate burst size and steady state ATPase activities stimulated by K + -EDTA, Ca ++ , Mg ++ , and actin. The antibodies were chosen for their ability to recognize selectively the rat VI and V3 cardiac isomyosins. The first type was a monoclonal antibody, CCM-52, prepared against embryonic chick cardiac myosin, the second was an anti-beef atrial myosin, and the third was an anti-rat VI myosin. CCM-52 reacted with a greater affinity with rat V3 than with rat VI, and was thus a probe of mammalian V3. Anti-beef atrial myosin and anti-rat VI myosin both recognized specifically beef atrial and rat VI myosins, and were thus considered as probes of mammalian VI. Under non-denaturing conditions, human myosins migrated as rat V3 isomyosin; under denaturing conditions, no difference was observed in any of the elecrrophoreric parameters between all samples tested, except for the fetal hearts which contained a fetal type of light chain. The immunological studies indicated that human myosins were composed mostly of a V3 type (HV3), but contained also some VI isomyosin. A technique was developed to quantify the amount of human VI isomyosin which was found to range from almost 0 to 15% of total myosin, and to vary from one heart to the other, regardless of the origin of the heart. Enzymatic studies showed no significant difference between normal, hypertrophied, and fetal hearts in any of the activities tested. However, there was a significant correlation between Ca ++ -stimulated ATPase activities and HV1 amount (at 0.05 M KG, n = 18, r 2 = 0.49, P < 0.01; at 0.5 M KC1, n = 18, r 2 = 0.5, P < 0.01). These data demonstrate the heterogeneity of human ventricular myosin, which appears to be composed, as in other mammalian species, of VI and V3 isoforms of different ATPase activities (VI > V3). However it seems that VI to V3 shifts do not appear to be of physiological significance in the adaptation of human heart to chronic mechanical overloads. (Circ Res 53: 52-62, 1983) 
SUMMARY. We tested the hypothesis that hypertrophy of the human heart is associated with the redistribution of ventricular isomyosins. Human cardiac myosin was isolated from autopsy samples of left ventricular free wall of patients with cardiac hypertrophy and of fetal, young, and adult subjects without heart disease. The following parameters were studied: elecrrophoreric migration in denaturing and non-denaturing conditions; immunological cross-reactivities with three different types of antibodies; and early phosphate burst size and steady state ATPase activities stimulated by K + -EDTA, Ca ++ , Mg ++ , and actin. The antibodies were chosen for their ability to recognize selectively the rat VI and V3 cardiac isomyosins. The first type was a monoclonal antibody, CCM-52, prepared against embryonic chick cardiac myosin, the second was an anti-beef atrial myosin, and the third was an anti-rat VI myosin. CCM-52 reacted with a greater affinity with rat V3 than with rat VI, and was thus a probe of mammalian V3. Anti-beef atrial myosin and anti-rat VI myosin both recognized specifically beef atrial and rat VI myosins, and were thus considered as probes of mammalian VI. Under non-denaturing conditions, human myosins migrated as rat V3 isomyosin; under denaturing conditions, no difference was observed in any of the elecrrophoreric parameters between all samples tested, except for the fetal hearts which contained a fetal type of light chain. The immunological studies indicated that human myosins were composed mostly of a V3 type (HV3), but contained also some VI isomyosin. A technique was developed to quantify the amount of human VI isomyosin which was found to range from almost 0 to 15% of total myosin, and to vary from one heart to the other, regardless of the origin of the heart. Enzymatic studies showed no significant difference between normal, hypertrophied, and fetal hearts in any of the activities tested. However, there was a significant correlation between Ca ++ -stimulated ATPase activities and HV1 amount (at 0.05 M KG, n = 18, r 2 = 0.49, P < 0.01; at 0.5 M KC1, n = 18, r 2 = 0.5, P < 0.01). These data demonstrate the heterogeneity of human ventricular myosin, which appears to be composed, as in other mammalian species, of VI and V3 isoforms of different ATPase activities (VI > V3). However it seems that VI to V3 shifts do not appear to be of physiological significance in the adaptation of human heart to chronic mechanical overloads. (Circ Res 53: 52-62, 1983) REGULATION of cardiac contractility by changes in the expression of a particular form of myosin was recently demonstrated in several experimental models. Each molecule of myosin is composed of two heavy and four light chains. Two different types of heavy chains, a and /3, were found in the ventricular myocardium of rats, rabbits, mice, pigs, and guinea pigs (cf Mercadier et al., 1981; , for reviews). It is generally admitted that, at least in rats and rabbits, these two heavy chain types associate to form myosin molecules composed either of an aa homodimer, or an aft heterodimer, or a ftp homodimer, which correspond, respectively, to the VI, V2, and V3 isomyosins discovered by Hoh et al. (1978) . The ratio of these isomyosins is not static, but varies according to the physiological and pathological state of the cardiac muscle: for example, in rats, V3 predominates in fetuses whereas adults contain mainly VI (Hoh et al., 1978; Lompre et al., 1981) and the V3 form reappears in hypothyroidic adults (Schwartz et al., 1982) , and probably also in cardiac hypertrophy. The type of myosin isozyme present appears to be an important determinant of the contractile activity of cardiac muscle: VI exhibits higher Ca ++ and actin-activated ATPase activities than V3 (Hoh et al., 1978; Pope et al., 1980; Lompre et al., 1981; Litten et al., 1982) , and the change from VI to V3 is correlated to a decrease in speed of muscle contraction Ebrecht et al., 1982) with, in parallel, an economy of force generation Mulieri, 1981, 1982) and a decrease in oxygen consumption (Kissling et al., 1982) . These results led to the concept that myosin isoenzymatic changes constitute an adaptive change of the myocardial cell which contributes, together with heart hypertrophy, to adaptation of heart muscle to new functional requirements.
Little experimental evidence exists for involvement of myosin isoenzymatic changes in the regu-lation of human cardiac contractility, and the data are rather contradictory. The pioneer work of Alpert and Gordon (1962) described a 20-30% decrease of myofibrillar ATPase activitiy of autopsy material obtained from hypertrophied hearts of patients showing evidence of heart failure. Leclercq and Swynghedauw (1976) confirmed these findings, but observed that the activities of myofibrils of moderately hypertrophied hearts were similar to those of controls. Peters et al. (1977) analyzed the crude tissular extracts of endomyocardial biopsies. Using highly sensitive assays, they found that patients with hypertrophic cardiomyopathy exhibited essentially normal myofibrillar Ca ++ -activated ATPase, whereas patients with congestive cardiomyopathy showed reduced levels of this enzymatic activity. Maron et al. (1977) , on the other hand, observed no difference in the K + -EDTA and Ca ++ -activated ATPase of myosins isolated from pre-operative samples of patients with asymetric septal hypertrophy. Recently, a very complete study was performed by the same laboratory on autopsy samples from adults, infants, and patients with primitive and secondary hypertrophic cardiomyopathies (Schier and Adelstein, 1982) . Myosins from all these hearts exhibited the same Ca ++ -stimulated ATPase activities. Moreover, in spite of the use of some of the more recently developed techniques for the detection of myosin isozymes, i.e., pyrophosphate gels and one-and two-dimensional peptide maps after chemical cleavage, these authors found no evidence for the existence of several myosin isoforms in the human ventricle.
A very discriminant approach to demonstrate myosin heterogeneity is the application of specific immunological methods. As a matter of fact, the first report of myosin structural changes in cardiac hypertrophy was based on immunological data (Schwartz et al., 1978) , and the use of specific immunoglobulins has proved of value in the detection, identification, localization, and even isolation of ventricular myocardial isomyosins (Sartore et al., 1979; Lompre et al., 1979; Schiaffino et al., 1980; Gorza et al., 1981; Sartore et al., 1981; Chizzonite et al., 1982; Clark et al., 1982; Schwartz et al., 1982; Samuel et al., 1983) . The aim of this study was to investigate whether there was an immunological evidence in the human heart for myosin heterogeneity and, if so, of isomyosin shifts during ontogenic development and compensatory hypertrophy. For this purpose, three different types of antibodies were selected, each one showing different specificities: a monoclonal antibody specific for rat and rabbit V3 isomyosins , and two polyclonal antibodies, one specific for rat VI isoform (Schwartz et al., 1982) , and the other specific for beef atrial myosin . Elecrrophoretic and enzymatic assays were also performed, so that correlations between structural and functional data would be obtained.
Methods

Patient Selection and Clinical Data
The biochemical and immunological studies reported in this work are based on analyses of autopsy samples of ventricular myocardium obtained from 7 fetuses, one child (9 years), 5 adult patients without heart disease, and 10 adult patients with hypertrophic hearts. These samples were generously provided by Dr. Macce, Hopital SaintVincent de Paul, Paris, and by Dr. A. Lavergne, Hopital Lariboisiere, Paris. Table 1 lists pertinent clinical information for each tissue specimen individually. Seven patients had medical histories of hypertension, and their heart weights varied from 300 to 600 g. One patient (no. 50) had an important mitral regurgitation with mild mitral stenosis (heart weight 450 g). The two larger hearts came from one patient (no. 37) with aortic incompetence (heart weight 660 g) and one patient (no. 36) with mitral regurgitation (heart weight 820 g). None of the patients exhibited signs of congestive left ventricular failure, except patient number 22, who died of pulmonary edema due to one hypertensive attack. Patients 50 and 37 died of postoperative low cardiac output syndrome.
The fetal hearts were specimens from fetuses died either in utero or from respiratory distress syndrome. None had evidence of cardiac pathology. For adult hearts, only the free wall of the left ventricle was used. It was cut up in fragments of 2-3g, blotted dry, frozen in liquid nitrogen, and stored at -40°C less than 12 hours after death. The total left ventricle of fetal hearts was used.
Animal Models
The study involved rat and beef hearts. Two groups of rats from the Wistar strain were used. In the first group (« = 30), rats were killed at 3 weeks of age, and in the second group (n = 30), rats were hypophysectomized at 10 weeks and killed 7 weeks later. These two groups were used to prepare rat VI and rat V3 isomyosins, respectively. All rats were killed by a sharp blow on the neck, and the hearts were rapidly excised. The atria and the large vessels were removed. The right and left ventricles were blotted dry, frozen in liquid nitrogen, and kept at -20°C until use. Beef hearts were removed 6-8 hours after being killed in a slaughter house, and the atria and right and left ventricles were dissected and kept at -20° C.
Preparation of Myosin and Actin
Rat and human ventricular myosins were prepared as described by Offer et al. (1973) with slight modifications (Lompre et al., 1979) . This method gives a yield of 6-10 mg myosin/g wet tissue. Bovine myosins were isolated essentially as described by Barany and Close (1971) and purified by ion-exchange chromatography (Richards et al., 1967) . Pepstatin (0.2 /ig/ml) was added throughout the preparation.
Actin was prepared from the fresh white muscle of the hind legs and back of rabbit. The method described by Spudich and Watt (1971) was used.
Electrophoretic Procedures
Pyrophosphate gel elecrrophoresis was performed essentially as described by Hoh et al. (1978) , except that the buffer (pH 8.5) contained 20 mM sodium pyrophosphate, 1 mM EDTA, 0.01% (vol/vol) 2-mercaptoethanol and 10% (vol/vol) glycerol (d 'Albis et al., 1979) . Elecrrophoresis in the presence of SDS was carried out on 15% polyacrylamide slab gels (140 X 150 X 1 mm, 10 mA/slab), according to the method of Whalen and Ecob (1982) . A 5% polyacrylamide stacking gel was always added.
Anti-Myosin Immunoglobulins
The preparation of monoclonal antibody CCM-52 against sodium dodecyl sulfate-denatured 12-day embryonic chick cardiac myosin is described in detail elsewhere (Clark et al., 1980) . The clone was derived from BALB/c mouse lymphocytes, and the immunoglobulins have been determined to be in the IgG-2a class. Ascites fluid from subcloned lines was used in the assays .
Anti-rat VI isomyosin antibodies (a-rt VI) were raised in guinea pigs and purified according to the method of Schwartz et al. (1982) . Two to three successive immunoaffinity chromatographies on insolubilized rat V3 myosin removed all antibodies cross-reacting with V3 isoform. The last step of purification was a fixation on a column of insolubilized rat VI myosin, followed by elution at pH 2.8 and immediate neutralization with 1 M phosphate buffer, pH 9. The immunoglobulins then were dialyzed with phosphate-buffered saline, and aliquots of 100 n\ were immediately frozen and kept at -20°C.
Anti-beef atrial myosin antibodies (a-bA) were obtained in rabbits as in Sartore et al. (1979) . The specific immunoglobulins were separated from the antisera by affinity chromatography on insolubilized atrial myosin, and were further adsorbed with insolubilized ventricular myosin to eliminate cross-reactive antibodies.
Enzyme-Linked Immunosorbent Assays
Direct and competitive ELJSA were performed on polystyrene plates according to the method of Engvall (1980) , with slight modifications (Schwartz et al., 1982) . The quantitative determination of rat VI or beef atrial myosins is described in detail elsewhere (Mercadier et al., in preparation) . In brief, the quantification, on human myosins, of the sites cross-reacting with a-rt VI, or a-bA immunoglobulins is based upon the comparison of the reactivity of these immunoglobulins with human myosins and standard mixtures of their corresponding sets of antigens (i.e., mixtures of rt-Vl and rt-V3 isomyosins for the a-rt VI immunoglobulins and mixtures of bA and bV isomyosins for the anti-bA immunoglobulins). Total myosin is maintained constant (0.5 jxg per well) and human myosins are used at the same concentration. The standard curve of such a method is shown on Figure 1 for the a-rt VI immunoglobulins. It is sigmoidal, but since only low values were of interest for us (see below), 50% VI was taken as the 100% absorbance control. Under these conditions, the function that best fitted experimental points was a power function (r 2 = 0.99, computed from six different experiments). The reprodudbility of the whole procedure is evidenced by the small size of the standard deviations (Fig. 1) .
Myosin ATPase
Determination of early phosphate burst size was carried out manually, as described by Taylor and Weeds (1977) and Van Thiem et al. (1978) , under stoichiometric conditions; 5 fiM myosin (= 10 ^M active site) and 10 fiM P] ATP were mixed on a Vortex mixer in the presence of 0.5 M KC1, 50 mM Tris-HCl, 5 mu MgCl 2 , and 0.1 mM dithiothreitol (pH 7.4, 22°C) and at several time intervals, aliquots were withdrawn and rapidly mixed with equal volumes of quenching solution ( 1 M HC1 and 0.35 M KH2PO4). The amount of 32 P released was determined after filtration on an activated charcoal/cellulose column. Ca ++ -stimulated ATPase activity was assayed in 5 mM CaCl 2 , 2.5 mM ATP, 50 mM Tris buffer, pH 7.5, 25°C, in the presence of 0.05 M KG (low ionic strength) or 0.5 M KC1 (high ionic strength). K + -EDTA-stimulated ATPase activity was assayed in the presence of 1 M KG and 5 mM EDTA. Mg ++ -stimulated and Mg^-actin-stimulated ATPase activities were assayed in 80 mM KG, 1.5 mM MgGi, 1 HIM ATP, 15 HIM Tris-HCl, pH 7.5, 30°C. When actin was present, the molar ratio actin/myosin was 60. All assays were stopped by the addition of 15% ice-cold trichloroacetic acid. Precipitated protein was removed by centrifugation, and inorganic phosphate levels were determined with malachite green (Lanzetta et al., 1979) .
Materials
Wistar rats were obtained from Iffa Credo, and New Zealand white rabbits from local breeders; [7-"P]ATP from Amersham; rabbit anti-guinea pig IgG and sheep anti-rabbit IgG, both conjugated with peroxidase, from the Institut Pasteur; CNBr-activated Sepharose 4B from Pharmacia; acrylamide and N,N' -methylene bisacrylamide from Serva; micro-ELISA plates M 129 B from Dynatech; o-phenylenediamine from Sigma. All other chemicals were reagent grade from Merck or Prolabo.
Statistics
Results were expressed as the mean ± SD. When two groups of data were compared, statistical comparisons were carried out using non-paired Student's f-test. Linear correlation was calculated using the method of least squares. Statistical significance was considered to be P < 0.05. Figure 2 shows the mobilities on native gel electrophoresis of ventricular myosins from one adult rat heart and three human hearts (one fetus, one normal adult, and one hypertrophied adult). The three classical isomyosin forms of the rat heart, VI, V2, and V3 were clearly detected, whereas only single bands were evident in the humans. Co-electrophoresis showed that human myosins co-migrate with the rat V3 isoform (Fig. 2 , lane e), which is consistent with previous observations Schier et al., 1982; Clark et al., 1982) . No differences were observed between normal adult and fetal myosins (co-migration, Fig. 2 lane f) or between adult normal and hypertrophied hearts (comigration, Fig. 2 lane g ). This similarity was consistently observed with all other human myosins tested (not shown), clearly indicating that pyrophosphate gel analysis did not allow detection of myosin heterogeneity in the human heart.
Results
Pyrophosphate and SDS Gel Electrophoresis
In the presence of SDS, the human myosins exhibited a satisfactory degree of purity, containing almost exclusively their heavy and light subunits (Fig. 3) . At the level of the light chains, three peptides were seen in the adult myosins, and four in the fetal ones. The third light chain of adults (LC 3 ) corresponded to the proteolytic product of LC 2 previously described by Klotz et al. (1982) . In the fef 9 FIGURE 2. Pyrophosphate gel electrophoresis of native human and rat cardiac myosins. Myosin a was purified from one rat heart submitted to chronic abdominal aortic stenosis (60% hypertrophy) and contained 56% V3; myosins b, c, and d were purified from heart of patients number 11, 50, and fetus number 30, respectively. Myosin e is a co-migration of myosin a and myosin purified from the heart of patient 24. Note that although myosins c and d contain 10.5% and 7.9% HV1, respectively (see Table 2 ruses, the peptide above LCi was the fetal light chain (Whalen and Sell, 1981; Price et al, 1980) .
Characterization of Anti-Myosin Antibodies
The characteristics of the monoclonal antibody CCM-52 were previously described by Chizzonite et al. (1982) and Clark et al. (1982) . It has been shown by means of indirect immunoprecipitation of 125 I-labeled myosins that this antibody reacted with rabbit V3 myosin with a 30 times higher apparent affinity than with rabbit VI isoform. In competitive radioimmunoassay, CCM-52 reacted one order of magnitude more with rat V3 than with rat VI, and its apparent affinity was the same for rat V3 and rabbit V3. This antibody was thus taken as a probe of mammalian V3 isomyosin.
The specificities of the anti-rat VI myosin towards rat VI myosin and of the anti-beef atrial myosin toward beef atrial myosin have also been reported in detail elsewhere (Schwartz et al., 1982, and Sartore et al., 1981, respectively) . In brief, a-rt VI reacts with rat VI and not with rat V3 myosin, and a-bA reacts with bovine left atrial and not with bovine left ventricular myosin. Both types of antibodies are specific for myosin heavy chains. To characterize Circulation Research/Vol. 53, No. 1, July 1983 further the immunological relationships between ventricular rat VI and beef atrial myosins, a-bA and a-rt VI immunoglobulins were reacted with rat VI, rat V3, beef atrial, and beef ventricular isomyosins. The results of these experiments are shown on Table  2 . In solid-phase direct ELISA, both types of immunoglobulins reacted specifically with beef atrial and rat VI myosins, whereas beef ventricular and rat V3 myosins were not recognized. The reactivity was greater in each case with the homologous antigen than with the heterologous antigen: a-bA reacted more with beef atrial myosin than with rat VI and, inversely, a-rt VI reacted more with rat VI isoform than with beef atrial myosin. These crossreactivities indicated that epitopes specific for rat ventricular VI myosin were present on beef atrial myosin, and conversely, that epitopes specific for beef atrial myosin were also present on rat VI isoform. This is consistent with the results of Dalla libera and , who showed that in competitive ELISA the apparent affinities of the abA antibodies for beef atrial and rabbit ventricular VI isomyosins were almost the same. All these observations led us to consider that both types of immunoglobulins, a-rt VI and a-bA, were probes of a mammalian ventricular VI (or atrial-like) isomyosin.
Direct and Competitive Immunosorbent Assays
The myosins from different human ventricles were compared by competitive and direct ELISA, and in each experiment, rat VI and V3 isoforms were used as controls.
A typical set of observations made in competitive assays is shown on Figures 4 and 5. With the CCM-52 (anti-V3) immunoglobulins (Fig. 4) , human myosins reacted with an apparent affinity very close to that of rat V3, and there was no significant differences between adult and fetal human myosins. The reactivity of rat VI isoform was one order of magnitude less. These observations, which indicated very strong homologies between human myosins and rat V3 isoform, were in full agreement with those previously reported by Clark et al. (1982) who used competitive radioimmunoassays. It was thus postulated that human myosins were composed es- Values are expressed as absorbances determined at 488 ran in direct ELISA assays.
•Diluted 1:320. f Diluted 1:200. sentially of a human V3 form, which we have called HV3. With the a-rt VI immunoglobulins (Fig. 5) , human myosins displayed a mixed pattern of reactivity: the a-rt VI immunoglobulins exhibited almost no affinity for some myosins, whereas other myosins definitely inhibited the binding of rat VI myosin to its homologous antibody. The apparent affinities of the a-rt VI antibody for those latter myosins were intermediate between those for rat VI and rat V3 isoforms. The relative affinities for each of these myosins were roughly quantified from the concentration required to inhibit 50% binding of the homologous antigen to the antibody. As shown in Figure 5 and Table 3 , the variations in relative affinities were independent from the origin of the heart-fetal, normal adult, or hypertrophied adult. This immunological cross-reactivity between a-rt VI and some human myosins clearly indicated the presence in some human hearts of a rat VI-like myosin, which we have called HV1. Fig. 5 ).
-f Calculated from direct ELJSA tests referred to standard curves (see Fig. 1 ). the a-rt VI antibodies for the different human myosins could be related to differences in the amount of this HV1 form, we have used a simple and quantitative direct ELISA test (Mercadier et al., in preparation) . The a-rt VI and a-bA immunoglobulins were used with their homologous sets of proteins as standards, i.e., rat VI and V3, or beef atrial and ventricular myosins, respectively. Table 3 summarizes all data obtained with this method. In both immune systems, the relative amount of the HV1 form was low and varied from one heart to the other. The values obtained with the a-rt VI immunoglobulins were always slightly lower than those obtained with the a-bA antibodies, but the correlation between the two systems was very good. In the a-rt VI system, 13 hearts contained less 2% HV1, five hearts contained between 4 and 10%, and one heart contained 14% HV1. In the a-bA system, these values were, respectively, 3 to 5.5%, 9 to 13% and the highest value was 18%. Apparently, there was no relation between the degree of hypertrophy and the amount of HV1, since hearts of approximately equivalent weights, numbers 22 and 50, contained 1.5% and 10.5% HV1, respectively. All these quantitative data were in very good agreement with the apparent affinities calculated from the competitive tests: those myosins which contained very small amounts of HV1 hardly inhibited the binding of rat VI myosin, whereas those containing 4 to 14% HV1 reacted significantly with the a-rtVl myosin.
Myosin ATPase Activities
A major problem in trying to measure human myosin ATPase activities on autopsy samples is to assess the integrity of the functional status of the molecule. Klotz et al. (1975) observed that the Ca ++ -activated ATPase of human myosin was not modified if the delay between death and the beginning of the myosin preparation was less than 24 hours. The size of the early burst of phosphate at the very beginning of ATP hydrolysis by myosin (Taylor and Weeds, 1977 ) appeared later to be a very good test for evaluating the functional status of cardiac myosin (Van Thiem et al., 1978) . We have thus used this technique to assess the condition of six of our myosins, and Figure 6 shows the typical time-course of such a determination. Extrapolation of the steady state phase to zero time indicated that 0.84 mol was fixed per active site, that is 1.68 per myosin head. Similar results were found for the six human myosins tested, including those from fetal hearts (Table  4) Circulation Research/Vol. 53, No. 1, July 1983 found by others on normal skeletal (Taylor and Weeds, 1977) or cardiac (Van Thiem et al., 1978; Lompre et al., 1979) muscles, clearly indicated that our preparations were neither aggregated nor oxidized, and thus could be considered as functionally intact.
The values of the ATPase activities of all human ventricular samples previously tested in ELISA, plus those of four additional fetal specimens, are shown on Table 4 . The reproducibility of the procedure for each myosin is evidenced by the standard deviations calculated from three different myosin preparations performed on the same heart. When myosin was activated by calcium in a medium containing 0.5 M or 0.05 M KG, no significant differences were observed between fetal, adult normal, and adult hypertrophied hearts. As for the K + -EDTA, the Mg ++ , and the Mg ++ -acrin-stimulated ATPase activities, they were not significantly different between each group.
In rats and rabbits, VI isoform exhibits a higher Ca ++ -stimulated activity than V3. It appeared thus of interest to compare the activities of the human hearts containing different levels of HV1, whatever the origin of the heart. There was a positive and significant correlation between Ca ++ -stimulated ATPase activity in the presence of 0.05 M or 0.5 M KC1 and the amount of HV1 (n = 18, r 2 = 0.49, P < 0.01 and n = 18 r 2 = 0.50, P < 0.01 respectively). In contrast, K + -EDTA-stimulated ATPase activity was not correlated with the amount of HV1. These correlations, although significant, deserve to be confirmed: the proportion of myosin samples showing the highest levels of HV1 was small compared with the samples exhibiting low levels of HV1.
Discussion
Myosin polymorphism in mammalian ventricular myocardium has been documented to date for several animal species. Rats and rabbits have been preferentially studied because in these species, elecrrophoresis under non-denaturing conditions allows a good and easy separation of the isomyosin types (Hoh et al., 1978; Lompre et al., .1979 Lompre et al., . , 1981 litten et'aL, ,1982) . In other species that contain only a single band by electrophoresis, i.e., pig, beef, and guinea pig, immunological analysis revealed also myosin heterogeneity . We show here that the myosin of human heart, which migrates as one band, contains also two isomyosins, a V3 type (HV3) and a VI type (HV1). The relative amount of HV1 is low and varies from one human heart to the other, regardless of the origin of the heart.
The monoclonal antibody which we have used, CCM-52, allowed us to establish the close relationship that exists between human ventricular myosin and mammalian V3 type myosins. In competitive ELISA, this antibody had an apparent affinity for human myosin almost equal to that for rat V3 iso- Values are mean ± SD of three different myosin purifications from the same left ventricular sample. Mean ± so represents the mean value ± standard deviation for each one of the three groups. * fimol Pi/mg per min. f mol ATP per mol myosin head.
myosin (Fig. 4) , which was in very good agreement with the data of Clark et al. (1982) . It appears thus that, according to this immunological criterion, most human myosin is composed of V3. However, the difference in apparent affinity for pure rat V3 and pure rat VI myosins is only one order of magnitude in this system. It is thus not surprising that we did not detect small amounts of VI with this antibody: 5% of this form would have produced.an almost indiscernible rightward shift of the inhibition curves. Conversely, the a-rt VI and a-bA polyclonal antibodies have acquired, after several affinity chromatography columns, an ability to react almost exclusively with rat VI and beef atrial specific epitopes (Schwartz et al., 1982; Sartore et al., 1981) . Our results ( Table 2 ) strongly suggest that both types of antibodies recognize a VI type isomyosin. Antigenic homologies between ventricular VI and atrial isomyosin have been reported in the rabbit by Dalla libera et al. (1981) and Clark et al. (1982) who used two very different immune systems. Moreover, the amount of cross-reactive epitopes detected by our two antibodies was grossly equal for each human myosin (Table 3) . From our data, it is not possible to determine whether the two antibodies are directed against the same epitope or against different epitopes, but it seems reasonable to assume that both can detect a VI-type myosin. Immunological data alone cannot constitute a definitive demonstration of the presence of two myosin heavy chain isoenzymes among human ventricular myosins, and pyrophosphate gel analysis always showed one band (Fig. 2) , suggesting that the two isoforms have the same charge. Our results are, however, an indisputable demonstration of the presence, within a certain number of human myosins, of antigenic epitopes cross-reacting with antibodies specifically directed against VI-type myosin. By analogy to what is known about ventricular myosin composition of more and more mammalian species, it seems likely that this is due to the existence in man of some a type heavy chain among a myosin that would be essentially composed of /S type heavy chain. Immunofluorescence studies on the human heart with a-bA have shown that the a heavy chain recognized by this antibody is heterogeneously distributed among human ventricular fibers , the frequency of reactive fibers in the different hearts corresponding to the relative amount of HV1 measured in the same specimens (Gorza et al., in preparation) . This myosin heterogeneity is consistent with the variations in pH sensitivity of the Ca ++ -stimulated ATPase activities recently observed by histochemical techniques within the human ventricular myocardium (Thomell and Forsgen, 1982) .
Quantification of HV1 among total ventricular myosin (Table 3 ) raises some questions. This evaluation is obtained by comparison of the antibody fixation with a standard which is composed, for each antibody, of its homologous myosins: rat VI and rat V3 for the a-rt VI system, and beef atrial and ventricular isomyosins in the a-bA system. It is likely that the affinities of the a-rt VI and a-bA antibodies toward their homologous antigens is greater than their affinities for HV1. Consistent with this is the definite, but slight, difference in the amounts of the HV1 calculated in the two systems (Table 3) , a difference which is probably due to a greater antigenic similarity of HV1 with bovine atrial myosin than with rat VI. The only reliable standard to quantitate HV1 would obviously be HV1 itself, but this form has not been purified so far. Moreover, the possibility that an antigenic site was slightly altered by proteolysis, resulting in a change in affinity of HV1 for the antibodies, cannot be discarded. It is thus possible that we underestimate the true level of HV1, but it is likely that this underestimation is small. Moreover, we do not evaluate the HV1 aa homodimer but the amount of total a type heavy chain. If, as in rat (Hoh et al., 1979) and rabbit , a heavy chain is distributed between an aa homodimer and an ap heterodimer the actual amount of aa homodimer, i.e., HV1, would be even lower than the evaluated values.
The low level of HV1 which we have found (Table  3 ) is in agreement with the overall Ca ++ -stimulated ATPase activities which are also rather low (Table  4) , since, in rats and rabbits, VI isoforms are responsible for high activity (Hoh et al., 1978; Lompre et al., 1979 Lompre et al., , 1981 Malhotra et al., 1981; Litten et al., 1982) . The attempt to correlate Ca ++ -stimulated ATPase activity and the amount of HV1 (see results) is questionable because of the small range of variations of both parameters and the scattering of the experimental points. Moreover, although the correlations are significant (P < 0.01), the values of the r 2 coefficients are poor (0.49 and 0.50). However, the extrapolated activity for 100% HV1 is 930 nmol Pj/mg per min, which is consistent with the general concept of VI and V3 isoforms of high and low ATPase activities, respectively. This low amount of HV1 varied from one heart to the other, in normal as well as in hypertrophied hearts (Table 3) . In animals, the number of reports concerning physioCirculation Research/Vol. 53, No. 1, July 1983 logical and pathological situations which influence cardiac isomyosin pattern increases rather rapidly: ontogenic development, ageing, physical training, thyroid hormones disturbances, chronic mechanical overloads, diabetes and even sex hormones alter isomyosin pattern (see Schwartz et al., 1982, for review; Malhorra et al., 1982) . It is likely that all these factors contribute to the heterogeneity that we have found among the different human hearts. On the other hand, it should be noticed that two of the three fetuses contained significant amounts of HV1, whereas all patients with high blood pressure showed almost no HV1. This might be indicative of a similarity of isomyosin genetic control in humans, rats, rabbits, and pigs. Contractile properties of myocardial fiber is closely related to Ca ++ -srimulated ATPase activity of the constituting myosin (cf Scheuer and Bahn, 1979, for review) or to isomyosin pattern Ebrecht et al, 1982) . Redistribution of the isoenzymic pattern with several physiological and pathological situations as heart hypertrophy or dysthyroidism has thus been considered as the molecular basis of alteration in myosin ATPase activities and contractile properties of heart muscle submitted to these various stresses. Mulieri (1981, 1982) have clearly established that this redistribution is beneficial for energetic economy of the contraction, since low myosin ATPase activity and low velocity of shortening improve the efficiency of contraction for an equivalent work. Is human heart affected by this adaptive phenomenon? We have carefully checked the functional integrity of our preparations (Fig. 6 ) and, in these conditions, we did not observe any significant changes of the Ca ++ -stimulated ATPase activities of myosins from moderately or severely hypertrophied hearts (Table 4) . Schier and Adelstein (1982) also found normal values for three patients suffering from high blood pressure, one of them even showing evidence of congestive heart failure. On the other hand, 20-30% decreases of myofibrillar ATPase activities have been reported with heart failure or very important heart hypertrophy (Alpert et al., 1962; Leclercq and Swynghedauw, 1976; Peters et al., 1977) . In view of the present findings and those of Schier and Adelstein (1982) , these decreases imply, if they are confirmed on precisely controlled human myofibrillar preparations, new mechanisms of regulation of ATP hydrolysis at the sarcomeric level.
In the ventricular myocardium of rats and rabbits, a balance between VI and V3 isomyosins is a major determinant of myocardial fiber contractility. Our data demonstrate that isomyosin shifts are possible in humans, but that they are quantitatively small, without noticeable influence on overall ATPase activities and apparently not related to the extent of cardiac hypertrophy. This strongly suggests that in man, isomyosin shifts do not or hardly contribute to adaptation to chronic mechanical overload. Analysis of a great number of heart samples in terms of their HV1 content and ATPase activities might now allow confirmation or infirmation of this hypothesis.
